News
Latest news
Pfizer Ventures gets behind OTR Therapeutics’s $100M series A to boost R&D hub’s capability

Fierce Biotech

December 05 2025
Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity

Kailera

October 14 2025
AbbVie (NYSE: ABBV) and ADARx Announce Collaboration and License Option Agreement

ADARx Pharmaceuticals

May 14 2025
Synnovation Announces First Patient Dosed in Phase I Trial with SNV4818, a Potential Best-In-Class Pan-Mutant-Selective PI3Kα Inhibitor for the Treatment of Solid Tumors

Business Wire

February 24 2025
Kailera Launches With $400M Series A And Clutch Of Chinese Obesity Drugs

Fierce Biotech

October 01 2024
CG Oncology Follows Big IPO With New Results For Bladder Cancer Drug

BioPharma Dive

May 03 2024

Get In Touch

Contact Us